Hodgkin’s Disease

Dec 26, 2016 by in ONCOLOGY Comments Off on Hodgkin’s Disease

Hodgkin’s Disease Dan L. Longo Hodgkin’s disease is a clonal lymphoid malignancy mainly confined to lymph nodes and lymphoid organs. For the period 1960–1963, 5-year survival from Hodgkin’s disease was…

read more

Renal Cell Carcinoma

Dec 26, 2016 by in ONCOLOGY Comments Off on Renal Cell Carcinoma

Renal Cell Carcinoma M. Dror Michaelson INTRODUCTION The incidence of renal cell carcinoma (RCC) in the United States has been rising steadily, with an estimated 65,150 cases and 13,680 deaths…

read more

Thymoma

Dec 26, 2016 by in ONCOLOGY Comments Off on Thymoma

Thymoma Panos Fidias INTRODUCTION Thymoma is a rare disease, with an incidence of only 0.13 per 100,000 person-years (1). However, it is the most common tumor of the anterior mediastinum,…

read more

Diffuse Large B-Cell Lymphoma

Dec 26, 2016 by in ONCOLOGY Comments Off on Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lympho Jennifer Gao, Ephraim Paul Hochberg Lymphomas are a malignancy arising from lymphoid cells, with more than 60 distinct variants identified by the World Health Organization (WHO)….

read more

Depression, Anxiety, and Fatigue

Dec 26, 2016 by in ONCOLOGY Comments Off on Depression, Anxiety, and Fatigue

Depression, Anxiety, and Fatigue Carlos G. Fernandez-Robles, William F. Pirl INTRODUCTION Depression, anxiety, and fatigue are frequent complications of cancer and cancer treatment. Although fatigue can be caused by depression…

read more

Immunomodulatory Drugs and Proteasome Inhibitors

Dec 26, 2016 by in ONCOLOGY Comments Off on Immunomodulatory Drugs and Proteasome Inhibitors

Immunomodulatory Drugs and Proteasome Inhibitors Anuj Mahindra, Hamza Mujagic, Bruce A. Chabner The therapeutic options for the treatment of multiple myeloma (MM) have expanded over the past decade with the…

read more

Febrile Neutropenia

Dec 26, 2016 by in ONCOLOGY Comments Off on Febrile Neutropenia

Febrile Neutropenia Stephen M. Carpenter, Fabrizio Vianello, Mark C. Poznansky INTRODUCTION Immune-compromised state refers to a change of the host defense systems that confer an increased susceptibility to infection. Neutropenia…

read more

Acute Lymphoblastic Leukemia and Lymphoma

Dec 26, 2016 by in ONCOLOGY Comments Off on Acute Lymphoblastic Leukemia and Lymphoma

Acute Lymphoblastic Leukemia and Lymphoma James W. Fraser, Janet E. Murphy, Eyal C. Attar INTRODUCTION Acute lymphoblastic leukemia (ALL) is a highly aggressive neoplasm of hematopoietic cells of lymphoid lineage….

read more
Get Clinical Tree app for offline access